IFNL2 and COVID-19: We found that IFN-λ1 and IFN-λ3 (now distinguishable from IFN-λ2 because of sequencing) segregated with subjects with mild COVID-19 and a high viral load compared to healthy controls or more severely ill COVID-19 patients (Figure 3A).